Table 1.
Characteristic | Effusion (N = 32) | No effusion (N = 2785) | Odds ratio (95% CI) | P-value |
---|---|---|---|---|
Body mass index | 25.7 ± 6.0 (32) | 27.8 ± 5.7 (2741) | 0.92 (0.86–1.00) | 0.038 |
BMI <20 kg/m2 | 15.6% (5/32) | 4.3% (117/2741) | 4.15 (1.57–10.98) | 0.004 |
Age (years) | 78.4 ± 13.6 (32) | 75.7 ± 12.7 (2782) | 1.02 (0.99–1.06) | 0.229 |
Age ≥75 | 65.6% (21/32) | 65.0% (1809/2782) | 1.03 (0.49–2.14) | 0.944 |
Age ≥85 | 46.9% (15/32) | 23.2% (646/2782) | 2.92 (1.45–5.87) | 0.003 |
Female | 62.5% (20/32) | 39.6% (1103/2783) | 2.54 (1.24–5.21) | 0.011 |
Cardiomyopathy | 15.6% (5/32) | 15.3% (427/2783) | 1.02 (0.39–2.67) | 0.965 |
Congestive heart failure | 28.1% (9/32) | 15.6% (433/2783) | 2.12 (0.98–4.62) | 0.058 |
Coronary artery disease | 15.6% (5/32) | 25.2% (702/2783) | 0.55 (0.21–1.43) | 0.220 |
Myocardial infarction | 15.6% (5/32) | 8.8% (246/2783) | 1.91 (0.73–5.00) | 0.188 |
Hypertension | 68.8% (22/32) | 69.8% (1942/2783) | 0.95 (0.45–2.02) | 0.900 |
Pulmonary hypertension | 12.5% (4/32) | 7.9% (220/2783) | 1.66 (0.58–4.79) | 0.345 |
Coronary artery intervention | 18.8% (6/32) | 14.8% (411/2783) | 1.33 (0.55–3.26) | 0.529 |
COPD | 28.1% (9/32) | 11.2% (313/2783) | 3.09 (1.42–6.73) | 0.005 |
Diabetes | 28.1% (9/32) | 27.5% (764/2783) | 1.03 (0.48–2.25) | 0.932 |
Preclusion for transvenous pacing | 18.8% (6/32) | 19.4% (540/2782) | 0.96 (0.39–2.34) | 0.925 |
AF history | 50.0% (16/32) | 72.9% (2028/2783) | 0.37 (0.19–0.75) | 0.006 |
Prior cardiac surgery | 12.5% (4/32) | 24.8% (690/2783) | 0.43 (0.15–1.24) | 0.119 |
On OAC | 67.7% (21/31) | 73.5% (2036/2769) | 0.76 (0.35–1.61) | 0.469 |
Renal dysfunction (any) | 25.0% (8/32) | 21.5% (597/2783) | 1.22 (0.55–2.73) | 0.627 |
Renal dysfunction (dialysis required) | 12.5% (4/32) | 7.0% (195/2783) | 1.90 (0.66–5.46) | 0.236 |
AF, atrial fibrillation; BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; OAC, oral anticoagulation.